Parkinsonian Disorders
"Parkinsonian Disorders" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A group of disorders which feature impaired motor control characterized by bradykinesia, MUSCLE RIGIDITY; TREMOR; and postural instability. Parkinsonian diseases are generally divided into primary parkinsonism (see PARKINSON DISEASE), secondary parkinsonism (see PARKINSON DISEASE, SECONDARY) and inherited forms. These conditions are associated with dysfunction of dopaminergic or closely related motor integration neuronal pathways in the BASAL GANGLIA.
Descriptor ID |
D020734
|
MeSH Number(s) |
C10.228.140.079.862 C10.228.662.600
|
Concept/Terms |
Parkinsonian Disorders- Parkinsonian Disorders
- Parkinsonian Syndrome
- Parkinsonism
- Parkinsonian Syndromes
- Parkinsonian Diseases
Autosomal Recessive Juvenile Parkinson Disease- Autosomal Recessive Juvenile Parkinson Disease
- Chromosome 6-Linked Autosomal Recessive Parkinsonism
- Chromosome 6 Linked Autosomal Recessive Parkinsonism
- Familial Parkinson Disease, Autosomal Recessive
- Juvenile Parkinson Disease, Autosomal Recessive
- Juvenile Parkinsonism, Autosomal Recessive
- Parkinsonism, Early Onset, with Diurnal Fluctuation
- Parkinsonism, Juvenile, Autosomal Recessive
- Parkinson Disease 2, Autosomal Recessive Juvenile
- Parkinsonism, Early-Onset, With Diurnal Fluctuation
- Parkinson Disease, Juvenile, Autosomal Recessive
- Parkinson Disease 2
- Parkinson Disease Autosomal Recessive, Early Onset
- Autosomal Recesssive Juvenile Parkinsonism
- Parkinson Disease, Familial, Autosomal Recessive
Parkinsonism, Experimental- Parkinsonism, Experimental
- Experimental Parkinsonisms
- Parkinsonisms, Experimental
- Parkinson Disease, Experimental
- Experimental Parkinsonism, MPTP-Induced
- Experimental Parkinsonism, MPTP Induced
- Parkinsonism, MPTP-Induced Experimental
- MPTP-Induced Experimental Parkinsonism
- MPTP Induced Experimental Parkinsonism
- Experimental Parkinson Disease
- Diseases, Experimental Parkinson
- Experimental Parkinson Diseases
- Parkinson Diseases, Experimental
- Experimental Parkinsonism
Parkinsonism, Juvenile- Parkinsonism, Juvenile
- Juvenile Parkinsonism
- Juvenile Parkinsonisms
- Parkinsonisms, Juvenile
- Parkinson Disease, Juvenile
- Juvenile Parkinson Disease
Autosomal Dominant Juvenile Parkinson Disease- Autosomal Dominant Juvenile Parkinson Disease
- Juvenile Parkinson Disease, Autosomal Dominant
- Parkinsonism, Juvenile, Autosomal Dominant
- Parkinson Disease, Autosomal Dominant. Juvenile
- Parkinson Disease, Juvenile, Autosomal Dominant
- Autosomal Dominant Juvenile Parkinsonism
- Juvenile Parkinsonism, Autosomal Dominant
|
Below are MeSH descriptors whose meaning is more general than "Parkinsonian Disorders".
Below are MeSH descriptors whose meaning is more specific than "Parkinsonian Disorders".
This graph shows the total number of publications written about "Parkinsonian Disorders" by people in this website by year, and whether "Parkinsonian Disorders" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
2001 | 0 | 1 | 1 | 2002 | 1 | 0 | 1 | 2006 | 1 | 1 | 2 | 2007 | 1 | 0 | 1 | 2008 | 1 | 0 | 1 | 2009 | 1 | 0 | 1 | 2010 | 1 | 0 | 1 | 2011 | 1 | 1 | 2 | 2012 | 1 | 0 | 1 | 2013 | 0 | 1 | 1 | 2014 | 1 | 0 | 1 | 2015 | 1 | 0 | 1 | 2016 | 1 | 0 | 1 | 2017 | 1 | 1 | 2 | 2019 | 4 | 0 | 4 | 2020 | 1 | 0 | 1 | 2021 | 3 | 0 | 3 | 2023 | 1 | 0 | 1 | 2024 | 0 | 1 | 1 | 2025 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Parkinsonian Disorders" by people in Profiles.
-
Vaillancourt DE, Barmpoutis A, Wu SS, DeSimone JC, Schauder M, Chen R, Parrish TB, Wang WE, Molho E, Morgan JC, Simon DK, Scott BL, Rosenthal LS, Gomperts SN, Akhtar RS, Grimes D, De Jesus S, Stover N, Bayram E, Ramirez-Zamora A, Prokop S, Fang R, Slevin JT, Kanel P, Bohnen NI, Tuite P, Aradi S, Strafella AP, Siddiqui MS, Davis AA, Huang X, Ostrem JL, Fernandez H, Litvan I, Hauser RA, Pantelyat A, McFarland NR, Xie T, Okun MS, Leader A, Russell ?, Babcock H, White-Tong K, Hua J, Goodheart AE, Peterec EC, Poon C, Galarce MB, Thompson T, Collier AM, Cromer C, Putra N, Costello R, Yilmaz E, Mercado C, Mercado T, Fessenden A, Wagner R, Spears CC, Caswell JL, Bryants M, Kuzianik K, Ahmed Y, Bendahan N, Njoku JO, Stiebel A, Zahed H, Wang SS, Hoang PT, Seemiller J, Du G. Automated Imaging Differentiation for Parkinsonism. JAMA Neurol. 2025 May 01; 82(5):495-505.
-
Latham AS, Rocha SM, McDermott CP, Reigan P, Slayden RA, Tjalkens RB. Neuroprotective efficacy of the glucocorticoid receptor modulator PT150 in the rotenone mouse model of Parkinson's disease. Neurotoxicology. 2024 Jul; 103:320-334.
-
Chiu SY, Wyman-Chick KA, Ferman TJ, Bayram E, Holden SK, Choudhury P, Armstrong MJ. Sex differences in dementia with Lewy bodies: Focused review of available evidence and future directions. Parkinsonism Relat Disord. 2023 02; 107:105285.
-
Simon OB, Buard I, Rojas DC, Holden SK, Kluger BM, Ghosh D. A novel approach to understanding Parkinsonian cognitive decline using minimum spanning trees, edge cutting, and magnetoencephalography. Sci Rep. 2021 10 05; 11(1):19704.
-
Kim DS, Kunicki ZJ, Philips OW, Jones RN, Friedman JH, Kluger B, Akbar U. Racial and geographic disparities with gastrostomy tube placement in dementia and parkinsonian disorders. Parkinsonism Relat Disord. 2021 10; 91:28-31.
-
Cai Y, Nielsen BE, Boxer EE, Aoto J, Ford CP. Loss of nigral excitation of cholinergic interneurons contributes to parkinsonian motor impairments. Neuron. 2021 04 07; 109(7):1137-1149.e5.
-
Liang LP, Fulton R, Bradshaw-Pierce EL, Pearson-Smith J, Day BJ, Patel M. Optimization of Lipophilic Metalloporphyrins Modifies Disease Outcomes in a Rat Model of Parkinsonism. J Pharmacol Exp Ther. 2021 04; 377(1):1-10.
-
Prizer LP, Kluger BM, Sillau S, Katz M, Galifianakis NB, Miyasaki JM. The presence of a caregiver is associated with patient outcomes in patients with Parkinson's disease and atypical parkinsonisms. Parkinsonism Relat Disord. 2020 09; 78:61-65.
-
Deuel L, Collins AE, Maa EH, Barr JP, Kern DS. Dravet syndrome and parkinsonism: A case report investigating the dopaminergic system. Neurology. 2019 09 24; 93(13):595-596.
-
Holden SK, Koljack CE, Prizer LP, Sillau SH, Miyasaki JM, Kluger BM. Measuring quality of life in palliative care for Parkinson's disease: A clinimetric comparison. Parkinsonism Relat Disord. 2019 08; 65:172-177.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|